News about Global Pharma

Vishnu Chemicals Announces Acquisition of Jayansree Pharma

Post-acquisition, JPPL will become a wholly-owned subsidiary of Vishnu Chemicals Limited, boosting the Group’s fixed asset by nearly INR 80 crore.

Global Pharma | 20/08/2024 | By Aishwarya |  1285

Titan Pharmaceuticals Enters into Merger Agreement with KE

Titan Pharmaceuticals, Inc. has signed a merger, contribution, and contribution and share exchange agreement, regarding a business combination with KE Sdn. Bhd. (KE).

Global Pharma | 20/08/2024 | By Aishwarya |  434

Sun Pharma to Invest Upto USD 15 Million for 5 Percent Stake in Pharmazz

Sun Pharma described the investment as strategic, noting it will gain exclusive rights to market and distribute Pharmazz’s drug, Sovateltide, in certain emerging markets.

Global Pharma | 17/08/2024 | By Aishwarya |  867

Lilly Completes Acquisition of Morphic

Morphic is a biopharmaceutical company developing oral integrin therapies for the treatment of serious chronic diseases, including a selective oral small molecule inhibitor of α4β7 integrin (known as MORF-057) for inflammatory bowel disease (IBD).

Global Pharma | 17/08/2024 | By Aishwarya |  615

PANTHERx Rare Collaborates with Gilead Sciences for Distribution of LIVDELZI

LIVDELZI is indicated for the treatment of primary biliary cholangitis (PBC), in combination with ursodeoxycholic acid (UDCA) in adults who have had an inadequate response to UDCA, or as monotherapy in patients unable to tolerate UDCA.

Global Pharma | 17/08/2024 | By Aishwarya |  343

Hoth Therapeutics Signs Deal with Aronnax for HT-KIT Cancer Therapeutic

Hoth Therapeutics has signed a Master Services Agreement with Aronnax, Inc. for its HT-KIT cancer therapeutic.

Global Pharma | 16/08/2024 | By Aishwarya |  583

Blue Earth Therapeutics Expands Partnership Deal with Seibersdorf Labor

Blue Earth Therapeutics Ltd. has expanded its manufacturing agreements with Seibersdorf Labor GmbH to include the manufacture of its investigational 225Ac-based radioligand therapy.

Global Pharma | 16/08/2024 | By Aishwarya |  574

Alembic Pharmaceuticals Gets FDA Approval for Dabigatran Etexilate Capsules

Dabigatran Etexilate Capsules 110 mg are indicated for prophylaxis of deep vein thrombosis and pulmonary embolism following hip replacement surgery. Refer label for a detailed indication.

Global Pharma | 16/08/2024 | By Aishwarya |  769

Lobe Sciences Establishes Wholly Owned Subsidiary Alera Pharma

Alera will be assigned the intellectual property rights focused on the company’s neurological assets and its new chemical entity Psilocin Mucate.

Global Pharma | 16/08/2024 | By Aishwarya |  1000

Wanbury Appoints Prakash Venkatraman as President of API Business

Wanbury Ltd. has appointed Prakash Venkatraman as President of the API business.

Global Pharma | 14/08/2024 | By Aishwarya |  610